Sun H, Huang D, Pang Y, Chen J, Kang C, Zhao M
FEMS Microbiol Rev. 2024; 48(6).
PMID: 39537200
PMC: 11644481.
DOI: 10.1093/femsre/fuae028.
Dyatlov I, Svetoch E, Mironenko A, Eruslanov B, Firstova V, Fursova N
Vaccines (Basel). 2022; 10(11).
PMID: 36366362
PMC: 9692684.
DOI: 10.3390/vaccines10111854.
Navarro A, Licona-Moreno D, Monsalvo-Reyes A, Hernandez-Chinas U, Eslava-Campos C
Microorganisms. 2020; 8(5).
PMID: 32455888
PMC: 7285282.
DOI: 10.3390/microorganisms8050780.
Obata F, Subrahmanyam P, Vozenilek A, Hippler L, Jeffers T, Tongsuk M
Front Microbiol. 2015; 6:262.
PMID: 25904903
PMC: 4389548.
DOI: 10.3389/fmicb.2015.00262.
Grisaru S
Int J Nephrol Renovasc Dis. 2014; 7:231-9.
PMID: 24966691
PMC: 4062558.
DOI: 10.2147/IJNRD.S41837.
Inhibition of water absorption and selective damage to human colonic mucosa are induced by subtilase cytotoxin produced by Escherichia coli O113:H21.
Gerhardt E, Masso M, Paton A, Paton J, Zotta E, Ibarra C
Infect Immun. 2013; 81(8):2931-7.
PMID: 23732168
PMC: 3719589.
DOI: 10.1128/IAI.00287-13.
Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease.
Fischer Walker C, Applegate J, Black R
J Health Popul Nutr. 2012; 30(3):257-61.
PMID: 23082627
PMC: 3489941.
DOI: 10.3329/jhpn.v30i3.12288.
Immune response to verotoxin 1 and 2 in children with Escherichia coli O157:H7 hemorrhagic colitis and classic hemolytic uremic syndrome.
Proulx F, Turgeon J, Delage G, Lior H, Lafleur L, Chicoine L
Can J Infect Dis. 2012; 6(3):136-40.
PMID: 22514385
PMC: 3327911.
DOI: 10.1155/1995/825478.
Serological response of Shiga toxin-producing Escherichia coli type III secreted proteins in sera from vaccinated rabbits, naturally infected cattle, and humans.
Asper D, Karmali M, Townsend H, Rogan D, Potter A
Clin Vaccine Immunol. 2011; 18(7):1052-7.
PMID: 21593239
PMC: 3147311.
DOI: 10.1128/CVI.00068-11.
Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods.
Fernandez-Brando R, Bentancor L, Mejias M, Ramos M, Exeni A, Exeni C
PLoS One. 2011; 6(4):e19136.
PMID: 21559455
PMC: 3084754.
DOI: 10.1371/journal.pone.0019136.
Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997-2003.
Schifferli A, von Vigier R, Fontana M, Sparta G, Schmid H, Bianchetti M
Eur J Pediatr. 2009; 169(5):591-8.
PMID: 19830454
DOI: 10.1007/s00431-009-1079-9.
Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coli.
Lopez E, Contrini M, Glatstein E, Gonzalez Ayala S, Santoro R, Allende D
Antimicrob Agents Chemother. 2009; 54(1):239-43.
PMID: 19822704
PMC: 2798559.
DOI: 10.1128/AAC.00343-09.
Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.
Obata F, Tohyama K, Bonev A, Kolling G, Keepers T, Gross L
J Infect Dis. 2008; 198(9):1398-406.
PMID: 18754742
PMC: 2684825.
DOI: 10.1086/591911.
Detection of diarrheagenic Escherichia coli by use of melting-curve analysis and real-time multiplex PCR.
Guion C, Ochoa T, Walker C, Barletta F, Cleary T
J Clin Microbiol. 2008; 46(5):1752-7.
PMID: 18322059
PMC: 2395066.
DOI: 10.1128/JCM.02341-07.
Development of an experimental hemolytic uremic syndrome in rats.
Zotta E, Lago N, Ochoa F, Repetto H, Ibarra C
Pediatr Nephrol. 2008; 23(4):559-67.
PMID: 18253762
DOI: 10.1007/s00467-007-0727-4.
Prevalence and virulence factors of Escherichia coli serogroups O26, O103, O111, and O145 shed by cattle in Scotland.
Pearce M, Evans J, McKendrick I, Smith A, Knight H, Mellor D
Appl Environ Microbiol. 2006; 72(1):653-9.
PMID: 16391103
PMC: 1352218.
DOI: 10.1128/AEM.72.1.653-659.2006.
Antibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults.
Navarro A, Eslava C, Hernandez U, Navarro-Henze J, Aviles M, Garcia-De la Torre G
Clin Diagn Lab Immunol. 2003; 10(5):797-801.
PMID: 12965907
PMC: 193889.
DOI: 10.1128/cdli.10.5.797-801.2003.
Detection of Escherichia coli O157:H7 and other intestinal pathogens in patients with diarrhoeal disease.
Baffone W, Ciaschini G, Pianetti A, Brandi G, Casaroli A, Bruscolini F
Eur J Epidemiol. 2001; 17(1):97-9.
PMID: 11523584
DOI: 10.1023/a:1010987808227.
Prevalence of bovine verotoxin-producing Escherichia coli in Argentina.
Sanz M, Vinas M, Parma A
Eur J Epidemiol. 1998; 14(4):399-403.
PMID: 9690760
DOI: 10.1023/a:1007427925583.
Diarrheagenic Escherichia coli.
Nataro J, Kaper J
Clin Microbiol Rev. 1998; 11(1):142-201.
PMID: 9457432
PMC: 121379.
DOI: 10.1128/CMR.11.1.142.